Are you Dr. Lin?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Baylor Plz
Msbcm187
Houston, TX 77030Phone+1 713-798-1835
Summary
- Dr. Weei-Chin Lin, MD is an oncologist in Houston, Texas. He is currently licensed to practice medicine in Texas, Alabama, and North Carolina. He is an Associate Professor at Baylor College of Medicine.
Education & Training
- National Taiwan University College of MedicineClass of 1986
Certifications & Licensure
- TX State Medical License 2010 - 2026
- AL State Medical License 2001 - 2009
- NC State Medical License 1999 - 2002
Publications & Presentations
PubMed
- 7 citationsA small-molecule inhibitor of TopBP1 exerts anti-MYC activity and synergy with PARP inhibitors.Fang-Tsyr Lin, Kang Liu, Lidija A Wilhelms Garan, Helena Folly-Kossi, Yongcheng Song
Proceedings of the National Academy of Sciences of the United States of America. 2023-10-31 - DNA2 Nuclease Inhibition Confers Synthetic Lethality in Cancers with Mutant p53 and Synergizes with PARP Inhibitors.Helena Folly-Kossi, Joshua D Graves, Lidija A Wilhelms Garan, Fang-Tsyr Lin, Weei-Chin Lin
Cancer Research Communications. 2023-10-16 - 3 citationsA novel prediction model of the risk of pancreatic cancer among diabetes patients using multiple clinical data and machine learning.Shih-Min Chen, Phan Thanh Phuc, Phung-Anh Nguyen, Whitney Burton, Shwu-Jiuan Lin
Cancer Medicine. 2023-10-01
Grant Support
- 14-3-3tau drives estrogen receptor loss and breast cancer progressionBAYLOR COLLEGE OF MEDICINE2023–2028
- Novel therapeutics for targeting checkpoint dysfunction in cancerBAYLOR COLLEGE OF MEDICINE2016–2027
- Novel therapeutics for targeting checkpoint dysfunction in cancerBAYLOR COLLEGE OF MEDICINE2016–2027
- Novel therapeutics for targeting checkpoint dysfunction in cancerBAYLOR COLLEGE OF MEDICINE2016–2027